Although the specific molecular and cellular mechanisms connecting EGFR and TLR signaling in CRC remain to be fully elucidated, it is evident that both pathways contribute significantly to cancer progression through mechanisms involving enhanced cell proliferation, survival, and inflammation-driven tumor growth [38, 41–46]. Here, EGFR is linked to colorectal carcinoma.